1.王伯徹,「菇類之食藥用價值及其多樣化市場產品開發」,農業生技產業季刊,第18期,第34-40頁(2009)。2.行政院農業委員會,「森林法第五十二條第四項所定貴重木之樹種」,農林務字第1041741162號公告,(2015)。
3.汪碧涵,「森林生態系中真菌扮演之角色及其在人工森林經營下之變動與影響」,林業研究專訊,第14卷,編號1,第23-25頁(2007)。4.何政坤、陳永修、許原瑞、張淑華,「牛樟樹育苗與栽種」,興大農業,第76期(2011)。
5.李世豪、謝育玲、廖宇賡,「以樟樹及相思樹枝梢材培養牛樟芝之初期生長及三萜類成分分析」,作物、環境與生物資訊,第9卷,第220-234頁(2012)。
6.李芝珊、黃紫羿,「行政院國家科學委員會專題研究計畫:油品成分對機車廢氣成分毒性影響之研究」,國立台灣大學公共衛生學院環境衛生研究所(2005)。
7.李順來(2016),「台灣國寶:牛樟芝(初版)」,台灣:世茂。
8.美國國家醫學圖書館(2017),取自https://ghr.nlm.nih.gov/primer/mutationsanddisorders/possiblemutations
9.徐銘豊,「樟芝(Antrodia camphorata)液態培養生產(1→3)-β-D-glucan 多醣體之硏究探討」,碩士論文,朝陽科技大學生物技術研究所,臺中(2006)。10.曾文楷、陳宜嫻、官常慶,「皂角刺萃取物對於溶血性與致突變性試驗之研究」,美容科技學刊,第五卷,第二期,第57-70頁(2008)。11.湯凱玲,「Ames測試法探討牛樟芝萃取物之致變異性與治癌性」,碩士論文,朝陽科技大學,台中(2016)。
12.蔣連財、張瑞烽、葉丙炎、曾銘豐、孫岩章,「台灣南部地區的環境污染物致突變性的調查」,醫藥科學期刊,第2卷,第304-309頁(1986)。
13.衛生福利部食品藥物管理署(2017),取自https://consumer.fda.gov.tw/Food/InfoHealthFood.aspx?nodeID=162#
14.衛生福利部食品藥物管理署,「健康食品安全性評估方法」,衛署食字第88037803號公告,(1999)。
15.衛生福利部食品藥物管理署,「藥品非臨床試驗安全性規範(第五版)」,FDA藥字第1031405812號公告,(2014)。
16.聶方珮、李嘉展、林雪良、林英才、彭清勇、鄭明得,「牛樟菇菌最適化固態培養條件與化學成份之探討」,台北海洋技術學院學報,第六卷,第二期,第58-71頁(2015)。
17.蕭祺暉、邱順慶、曾顯雄,「植物內生真菌的角色」,科學發展,520期,第38-45頁(2016)。
18.Ames, B. N., McCann, J., Yamasaki, E., “Method for detecting carcinogens and mutagens with the Salmonella/mammalial-microsome mutagenicity test.” Mutation Research/Environmental Mutagenesis and Related Subjects, Vol. 31, pp. 347-363 (1975).
19.Ashby, J., Tennant, R. W., “Chemical structure, Salmonella mutagenicity and extent of carcinogenicity as indicators of genotoxic carcinogenesis among 222 chemicals tested in rodents by the U.S. NCI/NTP,” Mutation Research/Genetic Toxicology, Vol. 204(1), pp. 17-115 (1988).
20.Biersack, B., “Current state of phenolic and terpenoidal dietary factors and natural products as non-coding RNA/microRNA modulators for improved cancer therapy and prevention,” Non-coding RNA Research, Vol. 1(1), pp. 12-34 (2016).
21.Bosio, C., Tomasoni, G., Martínez, R., Olea, A. F., Carrasco, H., Villena, J., ”Cytotoxic and apoptotic effects of leptocarpin, a plant-derived sesquiterpene lactone, on human cancer cell lines,” Chemico-Biological Interactions, Vol. 242, pp. 415-421 (2015).
22.Chiu, K. Y., Wu, C. C., Chia, C. H., Hsu, S. L., Tzeng, Y. M., “Inhibition of growth, migration and invasion of human bladder cancer cells by antrocin, a sesquiterpene lactone isolated from Antrodia cinnamomea, and its molecular mechanisms,” Cancer Letters, Vol. 373(2), pp. 174–184 (2016).
23.Chen, H. Y.,Yen, G. C., ”Review on the Dietary Antimutagens and Their Mechanisms of Action,” Nutritional Sciences, Vol. 21, No. 3, pp. 323-338 (1996).
24.Chiang, H. C., Wu, D. P., Cherng, I. W., Ueng, C. H., “A Sesquiterpene Lactone, Phenyl And Biphenyl Compounds From Antrodia Cinnamomea,” Phytochemistry, Vol. 39(3), pp. 613-616 (1995).
25.Chang, T. T. & Chou, W. N., Antrodia cinnamomea sp. nov. on Cinnamomum kamehirai in Taiwan. Mycological Research, Nov. 99(6), pp. 756-758 (1995).
26.Claxton, L. D., Umbuzeiro, G. de A., DeMarini, D. M., “The Salmonella mutagenicity assay: the stethoscope of genetic toxicology for the 21st century,” Environ Health Perspect, Nov. 118(11), pp. 1515-22 (2012).
27.Chena, Y. Ting., Shenb, Y. C., Changa, M. C., Lu, M. K., “Precursor-feeding strategy on the triterpenoid production andanti-inflammatory activity of Antrodia cinnamomea,” Process Biochemistry, Vol. 51, pp. 941-949 (2016).
28.Dias, D. A., Urban, S., Roessner, U., “A historical overview of natural products in drug discovery,” Metabolites, Vol. 2, pp. 303-336 (2012).
29.Hour, T. C., Liang, Y. C., Chu, I. S., Lin, J. K., “Inhibition of Eleven Mutagens by Various Tea Extracts, (-) Epigallocatechin – 3 - gallate, Gallic Acid and Caffeine.” Food and Chemical Toxicology, Vol. 37, pp. 569-579 (1999).
30.Kada, T., Kaneko, K., Matsuzaki, S., Matsuzaki, T., Hara, Y., “Detection and chemical identification of natural bio-antimutagens A case of the green tea factor,” Mutation Research, Vol. 150, pp. 127-132 (1985).
31.Llao, J. C., Flora of Taiwan, second edition, Lauraceae, Vol. 2, pp. 443 (1996).
32.Lee, S. J., Chen, J. H., Yang, M. F., Chang, G. C., “The Relevance Between Nutritional Intervention on Cancer patients’ Nutritional Status and Their Continual Process of Accepting Anti-cancer Treatment,” Journal of Nutritional Science, Vol. 37, No. 2, pp. 51- 65 (2012).
33.Lu, M. K., Lin, T. Y., Chao, C. H., Hu, C. H., Hsu, H. Y., “Molecular mechanism of Antrodia cinnamomea sulfated polysaccharide on the suppression of lung cancer cell growth and migration via induction of transforming growth factor receptor degradation” International Journal of Biological Macromolecules, Vol. 95, pp. 1144-1152 (2017).
34.Liao1, J. F., Chang, S. C., Chen, C. F., “Mutagenicity Testing Of The Crude Extracts Of 30 Chinese Drugs,” Chinese Medicine, Vol. 3(2), pp. 73-85 (1992).
35.Mccann, J., Ames, B. N., “Detection of carcinogens as mutagens in the Salmonella/microsome test: Assay of 300 chemicals: Discussion,” Medical Sciences, Vol. 73(3), pp. 950-954 (1976).
36.Meng, X., Liang, H., Luo, L., “Antitumor polysaccharides from mushrooms: a review on the structural characteristics, antitumor mechanisms and immunomodulating activities,” Carbohydrate Research, Vol. 424, pp. 30-41 (2016).
37.Qiaoa, X., Wanga, Q., Jia, S., Huanga, Y., Liua, K. d., Zhangb, Z. x., Bob, T., Tzengc, Y. m., Guoa, D. a., Yea, M., “Metabolites identification and multi-component pharmacokinetics of ergostane and lanostane triterpenoids in the anticancer mushroom Antrodia cinnamomea,” Journal of Pharmaceutical and Biomedical Analysis, Vol. 111, pp. 266-276 (2015).
38.Rao, Y. K., Wu, A. T. H., Geethangili, M., Huang, M. T., Chao, W. J., Wu, C. H., Deng, W. P., Yeh, C. T., Tzeng, Y. M., “Identification of Antrocin from Antrodia camphorata as a Selective and Novel Class of Small Molecule Inhibitor of Akt/mTOR Signaling in Metastatic Breast Cancer MDA-MB-231 Cells,” Chemical Research in Toxicology, Vol. 24(2), pp. 238–245 (2010).
39.Shi, L. S., Chao, C. H., Shen, D. Y., Chan, H. H., Chen, C. H., Liao, Y. R., Wu, S. J., Leu, Y. L., Shen, Y. C., Kuo, Y. H. Lee, E. J., Qian, K., Wu, T. S., Lee, K. H., “Biologically active constituents from the fruiting body of Taiwanofungus camphorates,” Vol. 19(1), pp. 677-683 (2011).
40.Stamets, P., “Novel antimicrobials from mushrooms,” Herbal Gram, Vol. 54, pp. 28–33 (2002).
41.Schulz, B., Boyle, C., Draeger, S., Römmert, A.K., Krohn, K., “Endophytic fungi: a source of novel biologically active secondary metabolites,” The British Mycological Society, Vol. 106(9), pp. 996-1004 (2002).
42.Wu, S. H., Ryvarden, L., & Chang, T. T., Antrodia camphorata (“niu-chang-chih”), new combination of a medicinal fungus in Taiwan. Bot. Bull. Academia Sinica, Vol. 38, pp. 273-275 (1997).
43.Yeh, C. T., Huang, W. C., Rao, Y. K., Ye, M., Lee, W. H., Wang, L. S., Tzeng, D. T. W., Wu, C. H., Shieh, Y. S., Huang, C. Y. F., Chen, Y. J., Hsiao, M., Wu, A. T. H., Yang, Z., Tzeng, Y. M., “A sesquiterpene lactone antrocin from Antrodia camphorata negatively modulates JAK2/STAT3 signaling via microRNA let-7c and induces apoptosis in lung cancer cells,” Carcinogenesis, Vol. 34, No. 12, pp. 2918–2928 (2013).
44.Zang, M., Sul, C. H., Ganoderma comphoratum, a new taxon in genus Ganoderma from Taiwan. China Acta Bot Yunnancia, Vol. 12, pp. 395-396 (1990).